Glaxo has now released their half year results for the year ending 2013. In the first half of the year, revenues in US and European pharmaceuticals ticked up slightly, along with Consumer Healthcare revenues. Emerging market pharmaceutical revenues were up … Continue reading
Tristel has now released their full year results for 2013. Falling revenues in Human Healthcare and Animal Healthcare were partially mitigated by a hike in Contamination Control revenue. During the year the agreement with the distributor in the Animal Healthcare … Continue reading
Ricardo has now released their results covering the full year end 2013. Technical Consulting provides services in relation to the development and implementation of engineering projects and in relation to management and operational consultancy, this segment contains the newly acquired … Continue reading
GVC has now released their half year results for 2013. Revenues are up across all areas but the largest increases are in Sportingbet and BSB revenue, reflecting the new acquisition. Variable costs are also up, but much less than … Continue reading
Havelock have now released their interim results for the half year end 2013 Revenues for the group reduced across all business areas. The loss of discontinued revenue with the sale of the businesses was counteracted by a very similar reduction … Continue reading
Laura Ashley has now issued their interim results for the half year to 2014. There is no doubt that the last 6 months have been difficult for Laura Ashley. Revenues were down across the board with store revenues down £6.2M, … Continue reading
Dechra has now released their full year results for 2013. Following the decision to sell the services division, there are only two reporting segments with the vast of majority of revenues earned by the European sector, up by £64M … Continue reading
980 Great West Road, Brentford, TW8 9GS Glaxosmithkline is a global healthcare group which is engaged in the creation, discovery, development, manufacture and marketing of pharmaceutical products including vaccines, over the counter medicines and health related consumer products. The pharmaceuticals … Continue reading
BP has now released their half year figures for 2013. Overall operational revenues were down. Upstream revenues fell by $1.2B while lower margin downstream revenues increased by $416M. The effects of the sale of the stake in TNK-BP affects … Continue reading
BP probably does not need much introduction, but in case anyone doesn’t know, they are an Oil and Gas company whose business model involves exploring for hydrocarbons, bringing them to the surface, moving them using pipelines, ships, trucks and trains, … Continue reading